# MAP3K1

## Overview
MAP3K1, or mitogen-activated protein kinase kinase kinase 1, is a gene that encodes a serine/threonine kinase, which is a critical component of the MAPK signaling pathway. This kinase, often referred to as MEK Kinase 1 (MEKK1), is involved in the regulation of various cellular processes, including gene expression, cell proliferation, migration, survival, and apoptosis. The protein encoded by MAP3K1 is categorized as a kinase due to its role in phosphorylating downstream targets, specifically activating MAP2K4 and MAP2K7, which in turn activate the JNK and p38 MAPKs. Additionally, MAP3K1 can influence the ERK and NF-κB pathways, highlighting its versatility in cellular signaling (Wang2021Genetic). The protein's structure includes domains that facilitate protein-protein interactions and ubiquitination, essential for modulating the cytoskeleton and regulating cell survival in response to stress and cytokine signals (Suddason2015A). MAP3K1's activity is crucial in both the cytoplasm and nucleus, impacting immune responses and developmental processes (Xia2000MEK).

## Structure


## Function
MAP3K1, also known as MEK Kinase 1 (MEKK1), is a serine/threonine kinase that plays a pivotal role in the MAPK signaling pathway, which is crucial for transmitting signals from the cell surface to the nucleus. This kinase is involved in various cellular activities, including gene expression, cell proliferation, migration, survival, and apoptosis. MAP3K1 preferentially activates MAP2K4 and MAP2K7, which subsequently activate the JNKs and/or p38 MAPKs, although it can also regulate the ERK and NF-κB pathways (Wang2021Genetic).

Structurally, MAP3K1 contains a kinase domain responsible for phosphorylating downstream MAP2Ks, and other domains like SWIM, RING, ARM, and TOG that mediate protein-protein interactions and ubiquitination processes. These interactions are crucial for modulating the cytoskeleton and regulating cell survival and death in response to cytokine and stress signals (Wang2021Genetic). MAP3K1 is active in both the cytoplasm and nucleus, impacting processes such as immune response and development (Suddason2015A).

In healthy human cells, MAP3K1 is essential for the activation of the JNK MAPK cascade in response to proinflammatory stimuli and growth factors, contributing to cellular responses to stress and proinflammatory signals (Xia2000MEK). It is also involved in cell migration, wound healing, and lymphocyte differentiation, indicating its importance in maintaining cellular functions (Suddason2015A).

## Clinical Significance
Mutations in the MAP3K1 gene are associated with a range of disorders, particularly affecting sex development and gonadal function. One of the primary conditions linked to MAP3K1 mutations is the 46,XY disorder of sex development (DSD), where individuals with a typically male karyotype exhibit ambiguous or feminized genitalia. These mutations often result in a gain of function, disrupting the balance between testicular and ovarian signaling pathways by enhancing WNT/β-catenin signaling and reducing SOX9/FGF9 expression, which are crucial for male sex development (Wang2021Genetic; Loke2013Mutations). 

MAP3K1 mutations can also lead to gonadal dysgenesis, characterized by incomplete or abnormal development of the gonads, and are implicated in conditions such as androgen insensitivity, where the body's response to male hormones is impaired (Granados2017MAP3K1‐related; Igarashi2020Nonsenseassociated). These mutations can affect the phosphorylation of downstream targets in the MAPK pathway, such as ERK1/2 and p38, further influencing the expression of key transcription factors involved in sex differentiation (Cheng2022Identification). 

In addition to sex development disorders, MAP3K1 mutations have been linked to congenital eye defects, including eyelid closure failure and corneal abnormalities, due to its role in eye development (Wang2021Genetic).

## Interactions
MAP3K1, also known as MEKK1, is involved in various protein interactions that are crucial for its role in signaling pathways. It specifically interacts with JNKK1 (also known as MAP2K4), forming stable complexes that determine signaling specificity. This interaction is unique to JNKK1, as MEKK1 does not interact with other MAPKKs like MEK1, MEK2, MKK3, MKK6, or JNKK2 (Xia1998JNKK1).

In the context of T cell signaling, MEKK1 interacts with the E3 ligase Itch through its N-terminal RING finger motif. This interaction is essential for the ubiquitination of JunB, a downstream target, and is dependent on the phosphorylation of MEKK1 at Thr 1381 (Enzler2009MEKK1).

MEKK1 also interacts with RhoA, a member of the Rho family GTPases, which binds to the amino-terminal one-third of MEKK1. This interaction is important for regulating MEKK1's kinase activity and is involved in cytoskeletal functions (Gallagher2004RhoA).

In the Wnt signaling pathway, MAP3K1 interacts with Axin1, a component of the β-catenin destruction complex. This interaction is enhanced by Wnt signaling and is crucial for TCF/LEF-driven transcription and the regulation of Wnt target genes (Sue2010MAP3K1).


## References


[1. (Wang2021Genetic) Jingjing Wang, Eiki Kimura, Maureen Mongan, and Ying Xia. Genetic control of map3k1 in eye development and sex differentiation. Cells, 11(1):34, December 2021. URL: http://dx.doi.org/10.3390/cells11010034, doi:10.3390/cells11010034. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells11010034)

[2. (Granados2017MAP3K1‐related) Andrea Granados, Veronica I. Alaniz, Lauren Mohnach, Hayk Barseghyan, Eric Vilain, Harry Ostrer, Elisabeth H. Quint, Ming Chen, and Catherine E. Keegan. Map3k1‐related gonadal dysgenesis: six new cases and review of the literature. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 175(2):253–259, May 2017. URL: http://dx.doi.org/10.1002/ajmg.c.31559, doi:10.1002/ajmg.c.31559. This article has 38 citations.](https://doi.org/10.1002/ajmg.c.31559)

[3. (Enzler2009MEKK1) Thomas Enzler, Xing Chang, Valeria Facchinetti, Gerry Melino, Michael Karin, Bing Su, and Ewen Gallagher. Mekk1 binds hect e3 ligase itch by its amino-terminal ring motif to regulate th2 cytokine gene expression. The Journal of Immunology, 183(6):3831–3838, September 2009. URL: http://dx.doi.org/10.4049/jimmunol.0803412, doi:10.4049/jimmunol.0803412. This article has 22 citations.](https://doi.org/10.4049/jimmunol.0803412)

[4. (Cheng2022Identification) Yiping Cheng, Chao Xu, Jiangfei Yang, Xinli Zhou, and Nan Chen. Identification of a novel map3k1 variant in a family with 46, xy dsd and partial growth hormone deficiency. Molecular Medicine Reports, September 2022. URL: http://dx.doi.org/10.3892/mmr.2022.12854, doi:10.3892/mmr.2022.12854. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/mmr.2022.12854)

[5. (Igarashi2020Nonsenseassociated) Maki Igarashi, Yohei Masunaga, Yuichi Hasegawa, Kenichi Kinjo, Mami Miyado, Hirotomo Saitsu, Yuko Kato-Fukui, Reiko Horikawa, Yomiko Okubo, Tsutomu Ogata, and Maki Fukami. Nonsense-associated altered splicing of map3k1 in two siblings with 46,xy disorders of sex development. Scientific Reports, October 2020. URL: http://dx.doi.org/10.1038/s41598-020-74405-1, doi:10.1038/s41598-020-74405-1. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-020-74405-1)

[6. (Loke2013Mutations) Johnny Loke, Alexander Pearlman, Orietta Radi, Orsetta Zuffardi, Ursula Giussani, Rosanna Pallotta, Giovanna Camerino, and Harry Ostrer. Mutations in map3k1 tilt the balance from sox9/fgf9 to wnt/β-catenin signaling. Human Molecular Genetics, 23(4):1073–1083, October 2013. URL: http://dx.doi.org/10.1093/hmg/ddt502, doi:10.1093/hmg/ddt502. This article has 72 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddt502)

[7. (Suddason2015A) T Suddason and E Gallagher. A ring to rule them all? insights into the map3k1 phd motif provide a new mechanistic understanding into the diverse roles of map3k1. Cell Death &amp; Differentiation, 22(4):540–548, January 2015. URL: http://dx.doi.org/10.1038/cdd.2014.239, doi:10.1038/cdd.2014.239. This article has 29 citations.](https://doi.org/10.1038/cdd.2014.239)

[8. (Gallagher2004RhoA) Ewen D. Gallagher, Stephen Gutowski, Paul C. Sternweis, and Melanie H. Cobb. Rhoa binds to the amino terminus of mekk1 and regulates its kinase activity. Journal of Biological Chemistry, 279(3):1872–1877, January 2004. URL: http://dx.doi.org/10.1074/jbc.m309525200, doi:10.1074/jbc.m309525200. This article has 69 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m309525200)

[9. (Xia2000MEK) Ying Xia, Constantin Makris, Bing Su, Erguang Li, Jianhua Yang, Glen R. Nemerow, and Michael Karin. Mek kinase 1 is critically required for c-jun n-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration. Proceedings of the National Academy of Sciences, 97(10):5243–5248, May 2000. URL: http://dx.doi.org/10.1073/pnas.97.10.5243, doi:10.1073/pnas.97.10.5243. This article has 227 citations.](https://doi.org/10.1073/pnas.97.10.5243)

[10. (Sue2010MAP3K1) Ser Sue Ng, Tokameh Mahmoudi, Vivian S.W. Li, Pantelis Hatzis, Paul J. Boersema, Shabaz Mohammed, Albert J. Heck, and Hans Clevers. Map3k1 functionally interacts with axin1 in the canonical wnt signalling pathway. Biological Chemistry, 391(2–3):171–180, February 2010. URL: http://dx.doi.org/10.1515/bc.2010.028, doi:10.1515/bc.2010.028. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.1515/bc.2010.028)

[11. (Xia1998JNKK1) Ying Xia, Zhenguo Wu, Bing Su, Brion Murray, and Michael Karin. Jnkk1 organizes a map kinase module through specific and sequential interactions with upstream and downstream components mediated by its amino-terminal extension. Genes &amp; Development, 12(21):3369–3381, November 1998. URL: http://dx.doi.org/10.1101/gad.12.21.3369, doi:10.1101/gad.12.21.3369. This article has 159 citations.](https://doi.org/10.1101/gad.12.21.3369)